These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11447462)

  • 21. Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells.
    Wolf K; Fischer E; Hackstadt T
    Infect Immun; 2005 Aug; 73(8):4560-70. PubMed ID: 16040967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
    Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
    Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of endothelial injury and platelet and macrophage interactions in atherosclerosis.
    Ross R; Faggiotto A; Bowen-Pope D; Raines E
    Circulation; 1984 Nov; 70(5 Pt 2):III77-82. PubMed ID: 6488507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlamydia pneumoniae and atherosclerosis.
    Ouchi K
    Jpn J Infect Dis; 1999 Dec; 52(6):223-7. PubMed ID: 10738358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
    Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
    Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydia pneumoniae-induced pathological signaling in the vasculature.
    Kern JM; Maass V; Maass M
    FEMS Immunol Med Microbiol; 2009 Mar; 55(2):131-9. PubMed ID: 19281565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth in vascular cells and cytokine production by Chlamydia pneumoniae.
    Gaydos CA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S473-8. PubMed ID: 10839742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlamydia pneumoniae and atherosclerosis--an update.
    Saikku P
    Scand J Infect Dis Suppl; 1997; 104():53-6. PubMed ID: 9259083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural features of human atherosclerosis.
    Perrotta I
    Ultrastruct Pathol; 2013 Feb; 37(1):43-51. PubMed ID: 21843056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural features of cell death in atherosclerotic lesions affecting long-term aortocoronary saphenous vein bypass grafts.
    Wang AY; Bobryshev YV; Cherian SM; Liang H; Inder SJ; Lord RS; Ashwell KW; Farnsworth AE
    J Submicrosc Cytol Pathol; 1999 Jul; 31(3):423-32. PubMed ID: 10626009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial infarction associated with Chlamydia pneumoniae.
    Phillips JI; Shor A; Murray J; Ong G; Taylor&hypen;Robinson D
    Cardiovasc J S Afr; 2000 Feb; 11(1):25-28. PubMed ID: 11447463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment.
    Evani SJ; Dallo SF; Ramasubramanian AK
    Front Microbiol; 2016; 7():1287. PubMed ID: 27582738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlamydial heat-shock protein 60 : A marker for chronic infection with Chlamydia Pneumoniae in atherosclerosis: Investigation of atherosclerotic coronary arteries by immunocytochemistry.
    Dettmeyer R; Stiel M; Madea B
    Forensic Sci Med Pathol; 2006 Sep; 2(3):173-8. PubMed ID: 25868695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain.
    Arking EJ; Appelt DM; Abrams JT; Kolbe S; Hudson AP; Balin BJ
    Pathogenesis (Amst); 1999; 1(3):201-211. PubMed ID: 20671799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis.
    Filardo S; Di Pietro M; Farcomeni A; Schiavoni G; Sessa R
    Mediators Inflamm; 2015; 2015():378658. PubMed ID: 26346892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannan-binding lectin in cardiovascular disease.
    Pągowska-Klimek I; Cedzyński M
    Biomed Res Int; 2014; 2014():616817. PubMed ID: 24877121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.
    Di Pietro M; Filardo S; De Santis F; Sessa R
    Int J Mol Sci; 2013 Jul; 14(7):15105-20. PubMed ID: 23877837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells.
    Dumrese C; Maurus CF; Gygi D; Schneider MK; Walch M; Groscurth P; Ziegler U
    BMC Microbiol; 2005 Jan; 5():2. PubMed ID: 15663783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis.
    Shor A; Phillips JI
    Cardiovasc J S Afr; 2000 Feb; 11(1):16-23. PubMed ID: 11447462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chlamydia pneumoniae in coronary plaques: Increased detection with acute coronary syndrome].
    Bauriedel G; Welsch U; Likungu JA; Welz A; Lüderitz B
    Dtsch Med Wochenschr; 1999 Apr; 124(13):375-80. PubMed ID: 10226644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.